Whether youre looking to transform your health, streamline your wellness journey, or receive personalized support, our program is designed to meet your needs
Data extraction and synthesis were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure methodological transparency and rigor
Wittmann G, Mohcsik P, Balkhi MY, Gereben B, Lechan RM
Statistics showed that more than 2,000 people would need to take a GLP-1 drug for one person to have a lower risk of colon cancer
Scientific References Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen - Summary of Product Characteristics
Although SGLT-2 inhibitors and GLP-1 receptor agonists do not increase the risk of severe hypoglycemia, SGLT-2 inhibitors increase the risk of genital infections, and GLP-1 agonists have gastrointestinal adverse effects, especially at initiation and with high doses